
Targeting the Toughest Diseases (Sponsored Content)
Bloomberg Businessweek
00:00
Targeting APOL1-Mediated Kidney Disease: Transformative Research and Raising Awareness
An exploration of Vertex Pharmaceuticals' groundbreaking research on APOL1-mediated kidney disease, including their efforts to develop transformative therapies and raise awareness for the devastating condition.
Transcript
Play full episode